Finally, the antidepressant effects of the developed formulation were investigated in wild-type (CBR1+/+) and cannabinoid receptor 1 knockout (CBR1−/−) mouse models of corticosterone-induced major depressive disorder. This evidence concerns the gene CBR1 and major depressive disorder.